August 20, 2024
TOPLINE: Automated analysis of CT-derived body composition parameters, especially the visceral fat index, can predict the new-onset risk for type 2 diabetes (T2D) better than traditional […]
August 20, 2024
TOPLINE: Genetic variants associated with Parkinson’s disease (PD) are more common than previously thought and occur in 13% of individuals with the disease. The study highlights […]
August 20, 2024
TOPLINE: Neoadjuvant immunotherapy in high-risk patients with hepatocellular carcinoma (HCC) led to similar recurrence-free survival (RFS) and margin-negative resection rates compared with patients undergoing upfront surgery. […]
August 20, 2024
TOPLINE: In patients with type 2 diabetes (T2D), tirzepatide is associated with a reduced risk for all-cause mortality, major adverse cardiovascular events (MACEs), major adverse kidney […]
August 20, 2024
TOPLINE: A new study confirms a protective effect of statin cholesterol-lowering drugs on liver cancer risk and suggests a similar effect with non-statin cholesterol absorption inhibitors. […]
August 19, 2024
TOPLINE: Ultrasonography reveals tendon involvement in nearly 70% of the patients with hand osteoarthritis (OA), with no significant impact on hand function or pain. Tendon damage […]
August 19, 2024
TOPLINE: Uterus transplants in women with absolute uterine-factor infertility resulted in a 70% success rate of women later giving birth. METHODOLOGY: The study included 20 women […]
August 19, 2024
TOPLINE: Stereotactic body radiotherapy (SBRT) is a safe treatment option for patients with oligometastatic cancer, with only 0.5% of patients experiencing severe acute toxicities within 6 […]
August 19, 2024
TOPLINE: An electronic decision support tool may increase the prescription of guideline–directed medical therapy for patients with acute heart failure (AHF) in emergency departments (EDs), with […]